Passage Bio, Inc. (PASG)
NASDAQ·Healthcare·Biotechnology
$5.77
+1.05%
Mkt Cap $27.94M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 3, 2026 | — | — | — | -$2.19 | -$4.08 | -86.30% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$2.64 | -$2.44 | +7.58% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$4.00 | -$2.96 | +26.00% | — | — |
| Q2 2025 May 13, 2025 | — | — | — | -$4.80 | -$5.00 | -4.17% | — | — |
| Q1 2025 Mar 4, 2025 | — | — | — | -$0.21 | -$0.20 | +4.76% | — | — |
| Q4 2024 Nov 13, 2024 | $1.67M | — | — | -$0.23 | -$0.31 | -34.78% | — | — |
| Q3 2024 Aug 8, 2024 | — | — | — | -$0.31 | -$0.26 | +16.13% | — | — |
| Q2 2024 May 14, 2024 | — | — | — | -$0.37 | -$0.30 | +18.92% | — | — |
| Q1 2024 Mar 4, 2024 | — | $5.91M | — | -$0.41 | -$0.30 | +26.83% | — | — |
| Q4 2023 Nov 13, 2023 | — | — | — | -$0.47 | -$0.49 | -4.26% | — | — |
| Q3 2023 Aug 7, 2023 | — | — | — | -$0.48 | -$0.44 | +8.33% | — | — |
| Q2 2023 May 11, 2023 | — | — | — | -$0.49 | -$0.63 | -28.57% | — | — |
| Q1 2023 Mar 6, 2023 | — | — | — | -$0.48 | -$0.50 | -4.17% | — | — |
| Q4 2022 Nov 10, 2022 | — | — | — | -$0.75 | -$0.49 | +34.67% | — | — |
| Q3 2022 Aug 4, 2022 | — | — | — | -$0.78 | -$0.73 | +6.41% | — | — |
| Q2 2022 May 16, 2022 | — | — | — | -$0.88 | -$0.79 | +10.23% | — | — |
| Q1 2022 Mar 3, 2022 | — | — | — | -$0.84 | -$0.93 | -10.71% | — | — |
| Q4 2021 Nov 4, 2021 | — | — | — | -$0.80 | -$0.77 | +3.75% | — | — |
| Q3 2021 Aug 5, 2021 | — | — | — | -$0.73 | -$0.90 | -23.29% | — | — |
| Q2 2021 May 5, 2021 | — | — | — | -$0.66 | -$0.76 | -15.15% | — | — |